Skip to main content

Table 3 Baseline characteristics of MHD patients with and without LVH

From: Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants

Variables

All (n = 131)

LVH (n = 80)

Non-LVH (n = 51)

P value

Demographics

    

Age (years)

60 (47, 69)

59.5 (49.5,70.5)

61 (46, 68)

0.479

Males (%)

 

53.75

66.67

0.151

Vintage (months)

48 (18, 104)

56(24, 114)

40 (17, 98)

0.196

BMI(kg/m2)

22.6 (20.3, 25.3)

22.8 (20.1, 25.4)

22.1 (20.5, 24.9)

0.489

ESRD causes (%)

   

–

Glomerulonephritis

49.6

53.8

43.1

 

Diabetic nephropathy

16.8

15.0

19.6

 

Hypertensive nephropathy

11.5

6.3

19.6

 

Others

22.1

25.0

17.7

 

Laboratory tests

    

Hgb (g/l)

114(108, 121)

115.5(108, 121)

113(107, 120)

0.283

Alb (g/l)

39.7(37.8, 41.8)

39.2 ± 3.2

39.7 ± 3.8

0.112

BUN (mmol/l)

28.2(23.5, 32.4)

28.8(23.5, 33.5)

27.6(22.9, 29.9)

0.132

Creatine (μmol/l)

1004 (852, 1191)

1011 (880, 1191)

983 (837, 1188)

0.513

UA (μmol/l)

449.6 ± 94.5

450 ± 101.8

448 ± 82.6

0.884

adjusted Ca (mmol/l)

9.4 ± 0.7

9.4 ± 0.7

9.4 ± 0.7

0.716

P (mmol/l)

1.62 ± 0.54

1.62 ± 0.56

1.64 ± 0.51

0.817

PTH (μg/ml)

173.0(96.4, 337.6)

186.5(107.4, 361.7)

163.7(58.1, 300.7)

0.186

LDL (mmol/l)

2.28 ± 0.81

2.21 ± 0.83

2.37 ± 0.76

0.271

HDL (mmol/l)

0.98(0.82, 1.25)

0.98(0.79, 1.25)

1.00(0.84, 1.24)

0.500

Total cholesterol (mmol/l)

4.11(3.51, 4.81)

4.27(3.72, 4.84)

4.00(3.46, 4.74)

0.402

Triglyceride (mmol/l)

1.94 (1.29, 2.75)

1.94 (1.22, 2.62)

1.90 (1.31, 3.16)

0.500

Total Protein (g/l)

70.68 ± 4.67

69.9 ± 4.05

71.9 ± 5.32

0.019

Glucose (mmol/l)

6.71(5.41, 9.18)

6.77(5.72, 9.02)

6.65(5.30, 9.68)

0.992

Potassium (mmol/l)

4.92 ± 0.75

5.05 ± 0.74

4.71 ± 0.73

0.014

Na (mmol/l)

138.0 ± 3.4

138.2 ± 3.3

137.6 ± 3.6

0.354

CO2CP (mmol/l)

23.8 ± 3.0

23.5 ± 2.9

24.4 ± 3.2

0.109

Dialysis related indices

    

spKt/V

1.49 ± 0.26

1.47 ± 0.27

1.51 ± 0.24

0.378

URR (%)

70.46 ± 7.26

70.03 ± 7.04

71.13 ± 7.63

0.411

Fistula use (%)

84.7

85.0

84.3

1.000

Intradialytic weight loss (kg)

2.7 (2.3, 3.2)

2.7 (2.3, 3.3)

2.5 (2.0, 3.0)

0.145

Clinical and echocardiography indices (%)

    

Pre-dialysis SBP (mmHg)

151 ± 16

154 ± 14

146 ± 17

0.004

Pre-dialysis DBP (mmHg)

76 ± 11

77 ± 12

75 ± 10

0.367

Post-dialysis SBP (mmHg)

145 ± 16

148 ± 15

141 ± 18

0.008

Post-dialysis DBP (mmHg)

79 ± 11

80 ± 12

79 ± 11

0.702

LVM (g)

197.5 (161.7, 262.0)

243.5 (199.1, 280.8)

149.0 (123.6, 181.9)

< 0.001

LVMI (g/m2)

115.0 (95.9, 144.7)

133.1 (120.9, 161.1)

87.7 (77.2, 97.7)

< 0.001

LVEF (%)

65.3 (59.3, 71.1)

63.3 (54.8, 69.2)

68.6 (63.1, 72.0)

0.003

MPA (cm)

2.3 (2.1, 2.5)

2.3 (2.2, 2.7)

2.2 (2.1, 2.4)

0.013

LAD (cm)

3.8 (3.4, 4.1)

3.9 (3.5, 4.4)

3.9 (3.3, 4.0)

0.005

IVSd (cm)

1.0 (0.9, 1.1)

1.1 (1.0, 1.2)

0.9 (0.8, 1.0)

< 0.001

LVIDd (cm)

5.0 (4.6, 5.4)

5.1 (4.9, 5.7)

4.5 (4.3, 5.0)

< 0.001

LVIDs (cm)

3.2 (2.8, 3.6)

3.4 (3.1, 3.9)

2.9 (2.7, 3.2)

< 0.001

PWT (cm)

0.97 (0.88, 1.10)

1.00 (0.90, 1.10)

0.90 (0.80, 1.00)

< 0.001

  1. BMI body mass index, Hgb haemoglobin, Alb albumin, spKt/V single-pooled Kt/V, stdKt/V standardized Kt/V, LVM left ventricular mass, LVMI left ventricular mass index, LVEF left ventricular ejection fraction, MPA main pulmonary artery diameter, LAD anteroposterior diameter of left atrium, IVSd interventricular septum at end-diastole, LVIDd left ventricular internal diameter at end-diastole, LVIDs left ventricular internal diameter at end-systole, PWT inferolateral wall thickness